Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreNo recent work listed

Geng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9038-4316; OpenAlex author ID A5100354410. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 3 papers

Papers 4

  1. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pa… Co-author DOI 10.1002/ijc.27736↗
  2. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-13-0362↗
  3. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-0209↗
  4. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0031507↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nader N Hanna · 4 shared papers, 2012–2013 · strength 0.12
  2. Β. Michael Ghadimi · 4 shared papers, 2012–2013 · strength 0.12
  3. Jochen Gaedcke · 4 shared papers, 2012–2013 · strength 0.12
  4. H. Richard Alexander · 4 shared papers, 2012–2013 · strength 0.12
  5. S. Perwez Hussain · 4 shared papers, 2012–2013 · strength 0.12
  6. Anirban Maitra · 3 shared papers, 2012–2013 · strength 0.09
  7. Naotake Funamizu · 2 shared papers, 2012–2013 · strength 0.05
  8. Michael B. Ghadimi · 1 shared paper, 2013 · strength 0.03
  9. Katsuhiko K. Yanaga · 1 shared paper, 2013 · strength 0.03
  10. Dong Ho Lee · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.